Biodegradable block copolymers

Advanced Drug Delivery Reviews

Volumn 53, Issue 1, 2001, Pages 23-44

  Kumar, N ^a   Ravikumar, M N V ^a   Domb, A J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Biodegradable; Block copolymer; Drug targeting; Hydrogels; Micelles; Microparticles; Nanoparticles; Poly(esters); Poly(ether ester amide); Poly(ether b ester); Star block copolymer; Surface modification

Indexed keywords

BIODEGRADATION; BIOMATERIALS; DRUG DOSAGE; HYDROGELS; MICELLES;

DRUG TARGETING;

BLOCK COPOLYMERS;

COPOLYMER; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG CARRIER; MACROGOL; NANOPARTICLE; POLOXAMER; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYLYSINE;

BIOCOMPATIBILITY; BIODEGRADATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RESEARCH; DRUG SPECIFICITY; DRUG TARGETING; HYDROGEL; MICELLE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; DRUG DELIVERY SYSTEMS; HUMANS; LACTATES; POLYETHYLENE GLYCOLS;

EID: 0035803750     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00219-8     Document Type: Review

References (138)

1. A biodegradable polymer as a cytokine delivery system for inducing bone formation
2. Novel synthetic selectively degradable vascular prostheses: A preliminary implantation study
3. Polymeric systems for controlled drug release
4. Polymeric controlled drug delivery systems: Perspective issues and opportunities
5. Reinforced poly(L-lactic acid) fibers as suture material
6. Resorbable materials of poly(L-lactide)
7. Development of a biodegradable wound covering and first clinical results
8. Microbial polyester synthesis: Effect on poly(ethylene glycol) on product composition, repeat unit sequence, and end group structure
9. Use of poly(ethylene glycols) to regulate poly(3-hydroxybutyrate) molecular weight during alcaligeneseutrophus cultivations
10. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin
11. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders
12. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer - Poloxamine 908
13. Modulation of marrow stromal cell function using poly(D, L-lactic acid)-b-poly(ethylene glycol)-mono methylether surfaces
14. Design and functional of novel osteoblast-adhesive peptides for chemical modification of biomaterials
15. Protein encapsulation in biodegradable amphiphilic microspheres. 1. Polymer synthesis and characterization and microsphere elaboration
16. In vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly(L(+)lactic acid-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks
17. Preparation of biodegradable polymer microspheres encapsulating protein with micron sizes
18. Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira interrogens antigens
19. Pareteral protein delivery systems using biodegradable polyester of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks
20. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: Protein stabilization and in vitro release properties
21. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks
22. Zero order release of lysozyme from poly(ethylene glycol)/poly(butylene terphthalate) matrices
23. Block copolymers as drug carriers
24. Synthesis and properties of novel block copolymers containing poly(lactic-glucolic acid) and poly(ethyleneglycol) segments
25. Degradation behaviour of block copolymers containing poly(lactic-glucolic acid) and poly(ethyleneglycol) segments
26. PMMA-block-poly(butylene)-b-PMMA prepared with α-ω-dilithiated polyisobutylene and its characterization
27. Poly(methylmethacrylate)-b-poly(isobutylene)-b-poly(methyl methacrylate) thermoplastic elestomers-synthesis, characterization and some mechanical properties
28. Suitability of poly(ethylene glycol) as dilution indicator in the human colon
29. Synthesis and characterization of block copolymers from D, L-lactide and poly(tetra methylene ether glycol)
30. Studies on the block copolymerization of D, L-lactide and poly(ethylene glycol) with aluminum complex catalyst
31. Preparation of block copoly(ester ether) comprising poly(L-lactide) and poly(oxypropylene) and degradation of its fibre in vitro and in vivo
32. Synthesis and characterization of block copolymers from D, L-lactide and poly(ethylene glycol) with stannous chloride
33. An improved interfacial coacervation technique to fabricate biodegradable nanocapsules of an aqueous peptide solution from polylactide and its block copolymers with poly(ethylene glycol)
34. Preparation of biodegradable polylactide-co-poly(ethylene glycol) copolymer by lactide reacted poly(ethylene glycol)
35. Inhibition of bovine serum-albumin adsorption by poly(ethylene glycol) soft segment in biodegradable poly(ethylene glycol) poly(L-lactide) copolymers
36. Estimation of the poly(ethylene glycol) chain-length of L-polylactide-polyethylene glycol in aqueous dispersons using viscoelestic measurements
37. Surface engineering and surface analysis of a biodegradable polymer with biotinylated end groups
38. Release of 5-fluorouracil by biodegradable poly(ester-ether-esters). Part I: Released by fused thin sheets
39. Synthesis and properties of biodegradable ABA triblock copolymers, consisting poly(L-lactic acid-co-glycolic acid) A-block attached to central polyoxyethylene B-blocks
40. In vitro degradation and bovine serum-albumin release of the ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks
41. Synthesis, characterization and in vitro degradation of star-block copolymers consisting of L-lactide, glycolide and branched multi-arm poly(ethylene oxide)
42. Star-shaped poly(ether-ester) block copolymers: Synthesis, characterization and their physical properties
43. Hyperbranched poly(ε-caprolactones)
44. Versatile and controlled synthesis of star and branched macromolecules by dentritic initiation
45. Dendrimer-like star polymers
46. Highly branched block copolymers: Design, synthesis and morphology
47. Synthesis and properties of A-B-A block copoly(ester-ethers) comprising poly(L-lactide) (A) and poly(oxypropylene-co-oxyethylene) (B) with different molecular weights
48. Properties and biodegradability of the fibers of block copoly(ester-ethers) comprising poly(L-lactide) and poly(oxypropylene-co-oxyethylene)
49. Synthesis and properties of poly(L-lactide) including polyether segments
50. Synthesis and properties of multiblock copolymers, consisting poly(L-lactic acid) and poly(oxypropylene-co-oxyethylene) prepared by direct polycondensation
51. Synthesis and characterization of PBS-PTMG segmented block copolymer
52. Synthesis of new degradable aliphatic polyester by transesterification: Synthesis of polyester containing aromatic structures
53. Synthesis and tensile properties of poly(butylene succinate) copolymer containing poly(butylene terephthalate) as the second component
54. Synthesis and characterization of hydroxy-terminated [RS]-poly(3-hydroxybutyrate) and its utilization to block copolymerization with L-lactide to obtain a biodegradable thermoplastic elastomer
55. Thermoplastic hydrogel based on hexablock copolymer composed of poly(γ-benzyl L-glutamate) and poly(ethylene oxide)
56. Amphiphilic poly(ether ester amide) multiblock copolymers as biodegradable matrices for the controlled release of proteins
57. Hydrolytic degradation of poly(ester amides) derived from carbohydrates
58. Synthesis, characterization and degradation of block polyesteramides containing poly(L-lactide) segments
59. Biological approaches to controlled delivery of drugs. A critical review
60. Serum factors that regulate phagocytosis of lyposomes by Kupffer cells
61. Serum opsonins and liposomes: Their interaction and opsonophagocytosis
62. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol rich liposomes
63. Long circulating microparticulate drug carriers
64. Colloidal delivery systems: Opportunities and challenges
65. The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338)
66. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations - Comparison to PEG
67. Blood compatibility of poly(ethylene oxide) surfaces
68. Doses poly(ethyleneoxide) possess a low thrombogenicity
69. Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and haprin for reduced thrombogenicity
70. Surface characterization of functionalized polylactide through the coating with heterobifunctional poly(ethylene glycol)/polylactide block copolymers
71. Self assembly of poly(ethylene glycol)-based block copolymers for biomedical applications
72. Biodegradable poly(D, L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: Structures and surface properties relevant to their use as biomaterials
73. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system
74. Proteins at interfaces: Principles, multivariate aspects, protein resistant surfaces and direct imaging and manipulation of adsorbed proteins
75. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers
76. Protein-surface interactions in the presence of polyethylene oxide
77. Preparation methods and structure of hydrogels
78. Synthetic hydrogels for biomedical applications
79. Differential scanning calorimetry of crystallized PVA hydrogels
80. PVA hydrogels: Reinforcement of radiation-crosslinked networks by crystallization
81. Micellization and gelation of aqueous-solutions of a triblock copolymer studied by reheological techniques and scanning calorimetry
82. Gelation of diblock copoly(oxyethylene oxybutylene) in aqueous solution
83. Concentrated aqueous micellar solutions of diblock copoly(oxyethylene/oxybutylene) E41B8: A study
84. Effect of chain-length on the micellization and gelation of block copoly(oxyethylene oxybutylene oxyethylene) EMBNEM
85. Thermoreversible gelation of PEG-PLGA-PEG triblock copolymers aqueous solutions
86. Thermoreversible gelation of poly(ethylene oxide) biodegradable polyester block copolymers. II
87. Temperature and pH-sensitive terpolymers for modulated delivery of streptokinase
88. Temperature and pH-sensitive polymers for human calcitonin delivery
89. Hydrogel systems for barriers and local drug delivery in the control of wound healing
90. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin
91. An anti-α-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier
92. Block copolymer micelles as long circulating drug vehicles
93. Nanoparticles
94. Particle engineering of biodegradable colloids for site-specific drug delivery
95. Site specific drug-carriers: Polymeric micelles as high potential vehicles for biologically active molecules
96. Polymeric micelles as new drug carriers
97. Block copolymer micelles as vehicles for drug delivery
98. Block ionomer complexes from polystyreneblock-polyacrylate anions and N-cetylpyridinium cations
99. Soluble complexes from poly(ethylene oxide)block-polymethacrylate anions and N-alkylpyridinium cations
100. Soluble stoichiometric complexes from poly(N-ethyl-4-vinylpyridinium) cations and poly(ethylene oxide)block-polymethacrylate anions
101. Chain length recognition: Core-shell supramolecular assembly from oppositely charged block copolymers
102. Preparation and characterization of self-assembled polymer-metal complex micelle from cisdichlorodiamine platinum (IT) and poly(ethylene glycol)poly(ot, p-aspartic acid) block copolymer in an aqueous medium
103. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D, L-lactide) block copolymer as potential drug carrier
104. Biodegradable long-circulating polymeric nanosphere
105. Development of amphiphilic diblock copolymers as micellar carriers of taxol
106. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartatic)
107. °-position in aqueous milieu
108. Block copolymer micelles for drug delivery: Design, characterization and biological significance
109. Water soluble polymers in medicine
110. Micelle forming block copolymers: Pinocytosis by macrophages and interaction with model membranes
111. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
112. Polymeric micelles as novel carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
113. Toxicity and anti-tumor activity against solid tumors of micelles-forming polymeric anticancer drug and its extremely long circulation in blood
114. Preparation of adriamycin-conjugated poly(ethylene glycol)poly(aspartic acid) block copolymer - A new type of polymcric anti-cancer agent
115. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin
116. Biodistribution of micelle-forming polymer-drug conjugates
117. Optimization of in vivo anti-tumor activity of micelle-forming polymeric drug against murine colon adenocarcinoma 26
118. Characterization and anti-cancer activity of micelle-forming polymeric anticancer drug, adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
119. Poly(N-isopropylacrylamide): Experimental and application
120. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers
121. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate)
122. Protein C-loaded monomethoxypoly(ethylene oxide)-poly(lactic acid) nanoparticles
123. Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties
124. Strategies for covalent attachment of doxorubicin to poly(PEG-Lys), a new water-soluble poly(ether urethane)
125. Biodegradable drug carriers based on poly(ethylene glycol) block copolymers
126. Synthesis of poly(ethylene glycol) block copolymers as potential water-soluble drug carriers
127. Poly(ethylene glycol) multiblock copolymers as a carrier of anti-cancer drug doxorubicin